×
For best experience we recommend to activate Javascript in your browser.
TACSTD2 antibody (AA 27-274)
This anti-TACSTD2 antibody is a Rabbit Polyclonal antibody detecting TACSTD2 in WB, IHC and ELISA. Suitable for Human, Mouse and Rat.
Quick Overview for TACSTD2 antibody (AA 27-274) (ABIN7571899)
Target
See all TACSTD2 Antibodies
TACSTD2
(Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
Reactivity
All reactivities for TACSTD2 antibodies
Human, Mouse, Rat
Host
All hosts for TACSTD2 antibodies
Rabbit
Clonality
All clonalities for TACSTD2 antibodies
Polyclonal
Conjugate
All conjugates for TACSTD2 antibodies
This TACSTD2 antibody is un-conjugated
Application
All applications for TACSTD2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
Product Details anti-TACSTD2 Antibody
(hide)
Binding Specificity
All epitopes for TACSTD2 antibodies
AA 27-274
Purpose
Anti-TACSTD2/TROP2 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human TACSTD2/TROP2 (His27-Thr274).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for TACSTD2
(hide)
Target
TACSTD2
(Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
Alternative Name
TACSTD2
Background
Pancreatic carcinoma marker protein GA733-1, Tumor-associated calcium signal transducer 2, M1S1, TROP2, TACSTD2, Cell surface glycoprotein Trop-2, GA733-1, Membrane component chromosome 1 surface marker 1
UniProt
P09758
Recently viewed
(hide)
Chat with us , powered by LiveChat